chr3-112931123-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138806.4(CD200R1):c.185C>T(p.Ser62Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000192 in 1,609,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138806.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD200R1 | NM_138806.4 | c.185C>T | p.Ser62Leu | missense_variant | 3/8 | ENST00000308611.8 | NP_620161.1 | |
CD200R1 | NM_170780.3 | c.116C>T | p.Ser39Leu | missense_variant | 2/7 | NP_740750.1 | ||
CD200R1 | NM_138939.3 | c.185C>T | p.Ser62Leu | missense_variant | 3/4 | NP_620385.1 | ||
CD200R1 | NM_138940.3 | c.116C>T | p.Ser39Leu | missense_variant | 2/3 | NP_620386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD200R1 | ENST00000308611.8 | c.185C>T | p.Ser62Leu | missense_variant | 3/8 | 1 | NM_138806.4 | ENSP00000311035.3 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251238Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135786
GnomAD4 exome AF: 0.000204 AC: 297AN: 1457720Hom.: 0 Cov.: 27 AF XY: 0.000205 AC XY: 149AN XY: 725430
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.185C>T (p.S62L) alteration is located in exon 3 (coding exon 3) of the CD200R1 gene. This alteration results from a C to T substitution at nucleotide position 185, causing the serine (S) at amino acid position 62 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at